A Covid-19 treatment plan slowly emerges | Evaluate
Articles about Mateon Therapeutics, Inc.
Windlas Biotech and Mateon Therapeutics Launch India's First Combined Lung Therapy and Ai Telemedicine 360 Solution to Transform Respiratory Wellness - The Pharma Times | Pharma & Health Care News Portal
Joint Venture Agreement relating to GMP Biotechnology Limited | MATEON THERAPEUTICS INC | Business Contracts | Justia
Windlas Biotech and Mateon Therapeutics to launch combined lung therapy, AI Telemedicine solution - Express Healthcare
Mateon launches antiviral programme focussed on Covid-19
Mateon Completes Its Acquisition of PointR Data Inc. - DATAVERSITY
Mateon Therapeutics
Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement PulmoHeal - FFOODS Spectrum - Unleashing the Power of Food Science & Technology
Mateon Therapeutics Company Profile: Valuation, Investors, Acquisition | PitchBook
MATEON'S C001- A GLOBAL PHASE 2 STUDY FOR OT-101 AGAINST
COVID Pandemic Hastens Search For New Technology And CRO Partner
FinData: Share Price for NASDAQ, MATN - Mateon Therapeutics Inc.
EDGAR Filing Documents for 0001493152-21-001207
Blockchain-Fueled Company Mateon Develops Phase 3 Clinical Drug Candidate, Against COVID-19 - OT-101 – Blockchain News, Opinion, TV and Jobs
Windlas Biotech and Mateon Therapeutics launch first-ever Drug-Device Lung Therapy Combined AI 360 platform for respiratory wellness - The Statesman
Zacks Small-Cap Research
About Us – Oncotelic
Mateon Therapeutics Announces Termination of FOCUS Study in
Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform - Express Pharma
Keeping an eye on Mateon Therapeutics (OTCQB: MATN) says GEN - Genetic Engineering & Biotechnology News - EmergingGrowth.com
Corporate Videos – Oncotelic
DEVELOPMENT UPDATE FOR ARTIVEDA™/ARTISHIELD™ AGAINST
Mateon Therapeutics completes acquisition of PointR Data
